HealthPrize Teams Up with RealAge to Improve Adherence
Unless taken, medicines don't work. Lack of medication adherence is a major issue contributing to poor health outcomes and higher costs. HealthPrize Technologies believes it has at least part of the solution, which is to provide an innovative approach with an online and mobile-based program that is fun, engaging and educational. This article summarizes the results of a six-month asthma and chronic obstructive pulmonary disease (COPD) pilot study in which HealthPrize partnered with RealAge to test patient engagement with the HealthPrize online and mobile platform.
Drugs are Losing the Battle Against Heart Disease. Here’s Why.
The percentage of the U.S. population taking at least one prescription drug during the past 30 days increased from 38% in 1988–1994 to 48%...
AstraZeneca’s Timely CRESTOR Branded Blog Post: Did It Violate Its Own Policy?
It's unusual for a pharmaceutical company to mention a product by brand name on its corporate blog. It's even more unusual to mention BOTH...
Pfizer Throws In the Lipitor Marketing Towel. Repercussions in Job Market Will Be Swift
Despite Pfizer's heroic and unprecedented effort to maintain Lipitor's market share after expiry last November and after spending "more than $87 million promoting the...
Have You Met Turbo & Scott? FTC May Want to Meet this eBook for...
I just found this tweet from @Novartis:
"US only: Have you met Turbo & Scott? Visit http://t.co/yJDtSvhQ to read the TSC eBook or download Barks...
Is 38 Hours Quick Enough to Respond to a Potentially Serious AE Tweet?
Subtitle: JNJ Responds to Adverse Event Reported Directly to @JNJComm via Twitter
There are probably more than 100 pharmaceutical company Twitter accounts such as @JNJComm,...
Obama’s Executive Order Spurs Drug Industry to Cooperate with FDA to Ease Drug Shortages
This week marks the six-month anniversary of President Obama signing an Executive Order to help FDA in its efforts to prevent and resolve prescription...
Pharma Support of CME Infographic
Pharma support of CME continues to decline, but at a slower rate.
"Other" Sources of Revenue (eg, registration fees, grants from gov't or independent foundations)...
Pfizer’s Lipitor Co-pay Card/PBM Discount Plan Fails
Yesterday, an attendee at the Marcus Evans PharmaMarketing Summit here in Chicago asked if Pfizer's innovative plan to extend the life of its Lipitor...

















